Liposomal antineoplastic drugs and uses thereof
US7452550B2 · kind B2 · utility
4Cited by
13References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 9, 2006 |
| Grant date | Nov 18, 2008 |
| Priority date | — |
| Expiry date | May 9, 2026 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/496
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to liposomal antineoplastic agents (e.g., camptothecin) compositions and methods of using such compositions for treating neoplasia and for inhibiting angiogenesis. The compositions and methods are useful for modulating the plasma circulation half-life of an active agent.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.